211 related articles for article (PubMed ID: 23665258)
1. Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer.
Desale SS; Cohen SM; Zhao Y; Kabanov AV; Bronich TK
J Control Release; 2013 Nov; 171(3):339-48. PubMed ID: 23665258
[TBL] [Abstract][Full Text] [Related]
2. Co-delivery of paclitaxel and cisplatin in poly(2-oxazoline) polymeric micelles: Implications for drug loading, release, pharmacokinetics and outcome of ovarian and breast cancer treatments.
Wan X; Beaudoin JJ; Vinod N; Min Y; Makita N; Bludau H; Jordan R; Wang A; Sokolsky M; Kabanov AV
Biomaterials; 2019 Feb; 192():1-14. PubMed ID: 30415101
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of platinum-taxane combination therapy in ovarian cancer.
Desale SS; Soni KS; Romanova S; Cohen SM; Bronich TK
J Control Release; 2015 Dec; 220(Pt B):651-9. PubMed ID: 26381902
[TBL] [Abstract][Full Text] [Related]
4. Ligand-installed polymeric nanocarriers for combination chemotherapy of EGFR-positive ovarian cancer.
Xi X; Lei F; Gao K; Li J; Liu R; Karpf AR; Bronich TK
J Control Release; 2023 Aug; 360():872-887. PubMed ID: 37478915
[TBL] [Abstract][Full Text] [Related]
5. Poly(ethylene glycol)-block-poly(ε-caprolactone) micelles for combination drug delivery: evaluation of paclitaxel, cyclopamine and gossypol in intraperitoneal xenograft models of ovarian cancer.
Cho H; Lai TC; Kwon GS
J Control Release; 2013 Feb; 166(1):1-9. PubMed ID: 23246471
[TBL] [Abstract][Full Text] [Related]
6. Polypeptide-based combination of paclitaxel and cisplatin for enhanced chemotherapy efficacy and reduced side-effects.
Song W; Tang Z; Li M; Lv S; Sun H; Deng M; Liu H; Chen X
Acta Biomater; 2014 Mar; 10(3):1392-402. PubMed ID: 24316362
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin-loaded core cross-linked micelles: comparative pharmacokinetics, antitumor activity, and toxicity in mice.
Oberoi HS; Nukolova NV; Laquer FC; Poluektova LY; Huang J; Alnouti Y; Yokohira M; Arnold LL; Kabanov AV; Cohen SM; Bronich TK
Int J Nanomedicine; 2012; 7():2557-71. PubMed ID: 22745537
[TBL] [Abstract][Full Text] [Related]
8. Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery.
Li Y; Xiao K; Luo J; Xiao W; Lee JS; Gonik AM; Kato J; Dong TA; Lam KS
Biomaterials; 2011 Sep; 32(27):6633-45. PubMed ID: 21658763
[TBL] [Abstract][Full Text] [Related]
9. Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer.
Lv S; Tang Z; Li M; Lin J; Song W; Liu H; Huang Y; Zhang Y; Chen X
Biomaterials; 2014 Jul; 35(23):6118-29. PubMed ID: 24794923
[TBL] [Abstract][Full Text] [Related]
10. Reduction-responsive crosslinked micellar nanoassemblies for tumor-targeted drug delivery.
Fan W; Wang Y; Dai X; Shi L; Mckinley D; Tan C
Pharm Res; 2015 Apr; 32(4):1325-40. PubMed ID: 25319102
[TBL] [Abstract][Full Text] [Related]
11. Facile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapy.
Ruttala HB; Chitrapriya N; Kaliraj K; Ramasamy T; Shin WH; Jeong JH; Kim JR; Ku SK; Choi HG; Yong CS; Kim JO
Acta Biomater; 2017 Nov; 63():135-149. PubMed ID: 28890258
[TBL] [Abstract][Full Text] [Related]
12. Multi-drug delivery to tumor cells via micellar nanocarriers.
Katragadda U; Teng Q; Rayaprolu BM; Chandran T; Tan C
Int J Pharm; 2011 Oct; 419(1-2):281-6. PubMed ID: 21820041
[TBL] [Abstract][Full Text] [Related]
13. Efficient Codelivery of Paclitaxel and Curcumin by Novel Bottlebrush Copolymer-based Micelles.
Yao Q; Gutierrez DC; Hoang NH; Kim D; Wang R; Hobbs C; Zhu L
Mol Pharm; 2017 Jul; 14(7):2378-2389. PubMed ID: 28605595
[TBL] [Abstract][Full Text] [Related]
14. Degradable cisplatin-releasing core-shell nanogels from zwitterionic poly(beta -aminoester)-graft-PEG for cancer chemotherapy.
Jin W; Xu P; Zhan Y; Shen Y; Van Kirk EA; Alexander B; Murdoch WJ; Liu L; Isaak DD
Drug Deliv; 2007 Jul; 14(5):279-86. PubMed ID: 17613015
[TBL] [Abstract][Full Text] [Related]
15. D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery.
Wu Y; Chu Q; Tan S; Zhuang X; Bao Y; Wu T; Zhang Z
Int J Nanomedicine; 2015; 10():5219-35. PubMed ID: 26316751
[TBL] [Abstract][Full Text] [Related]
16. Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary.
Takahashi R; Mabuchi S; Kawano M; Sasano T; Matsumoto Y; Kuroda H; Kozasa K; Hashimoto K; Sawada K; Kimura T
PLoS One; 2016; 11(3):e0151050. PubMed ID: 26986199
[TBL] [Abstract][Full Text] [Related]
17. Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.
Jiang C; Wang H; Zhang X; Sun Z; Wang F; Cheng J; Xie H; Yu B; Zhou L
Int J Pharm; 2014 Nov; 475(1-2):60-8. PubMed ID: 25152167
[TBL] [Abstract][Full Text] [Related]
18. Dual-drug delivery of curcumin and platinum drugs in polymeric micelles enhances the synergistic effects: a double act for the treatment of multidrug-resistant cancer.
Scarano W; de Souza P; Stenzel MH
Biomater Sci; 2015 Jan; 3(1):163-74. PubMed ID: 26214199
[TBL] [Abstract][Full Text] [Related]
19. [Preparation and properties of self-assemble paclitaxel-loaded core-shell type nano-micelles].
Yu Q; Pan SR; Du Z
Yao Xue Xue Bao; 2008 Apr; 43(4):408-14. PubMed ID: 18664205
[TBL] [Abstract][Full Text] [Related]
20. A novel polymer-paclitaxel conjugate based on amphiphilic triblock copolymer.
Xie Z; Guan H; Chen X; Lu C; Chen L; Hu X; Shi Q; Jing X
J Control Release; 2007 Feb; 117(2):210-6. PubMed ID: 17188776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
